- Hypertrophic Cardiomyopathy (HCM)
- Eyecare
- Urothelial Carcinoma
- Hemophilia
- Heart Failure
- Vaccines
- Neonatal Care
- NSCLC
- Type II Inflammation
- Substance Use Disorder
- Gene Therapy
- Lung Cancer
- Spinal Muscular Atrophy
- HIV
- Post-Acute Care
- Liver Disease
- Asthma
- Atrial Fibrillation
- COVID-19
- Cardiovascular Diseases
- Prescription Digital Therapeutics
- Reproductive Health
- The Improving Patient Access Podcast
- Blood Cancer
- Ulcerative Colitis
- Respiratory Conditions
- Multiple Sclerosis
- Digital Health
- Population Health
- Sleep Disorders
- Biosimilars
- Plaque Psoriasis
- Leukemia and Lymphoma
- Oncology
- Pediatrics
- Urology
- Obstetrics-Gynecology & Women's Health
- Opioids
- Solid Tumors
- Autoimmune Diseases
- Dermatology
- Diabetes
- Mental Health
5 Most-Read Articles From Our 2020 Publication
The most popular article from the Managed Healthcare Executive® print publication was a pre-pandemic story about the top 6 challenges facing healthcare executives.
Of course COVID-19 garnered most of the headlines in 2020. But the best-read stories from our print publication (which are subsequently posted on the website) covered a range of topics, from drugs in the pipeline to pulse oximeters to the top challenges for healthcare executives.
5. The Most Valuable Pipeline Drugs for 2020
Our predictions at the beginning of 2020 about the drugs headed for approval or sale. Reyvow (Lasmiditan), Adakveo (crizanlizumab-tmca) and Givlaari (givosiran) were on this pre-pandemic list.
4. At-Home Pulse Oximeters: The ‘It’ Gadget of the COVID-19 Outbreak
At-home pulse oximeter purchases have spiked 500% in the months after COVID-19 pandemic hit the United States because the disease lowers oxygen levels. The American Lung Association sounded a cautious note, advising against buying the device unnecessarily.
3. Five Healthcare Industry Changes to Watch in 2020
The 2020 trends we looked at included a shift from hospital to ambulatory settings, consolidation across the sector and effort to protect data privacy.
2. Top Pharmacy Regulations for 2020: What Pharmacists Should Know
Our story looked at limits on opioids, provisions in the Drug Supply Chain Security Act and pharmacists prescribing hormonal contraceptives.
1. Top 6 Challenges Healthcare Executives Will Face in 2020
COVID-19 overwhelmed every other challenges healthcare executives had in 2020. Our story in early January identified complying with new government regulations, a shift to value-based care and using big data as the hills that executives would be climbing in 2020.
Bridging the Diversity Gap in Rare Disease Clinical Trials with Harsha Rajasimha of IndoUSrare
November 8th 2023Briana Contreras, an editor with Managed Healthcare Executive, spoke with Harsha Rajasimha, MD, founder and executive chairman of IndoUSrare, in this month's episode of Tuning in to the C-Suite podcast. The conversation was about how the disparity in diversity and ethnicity in rare disease clinical trials in the U.S. has led to gaps in understanding diseases and conditions, jeopardizing universal health, and increasing the economic burden of healthcare.
Listen
Study Raises Concerns Over Insurance Barriers to HIV Prevention Medications
November 29th 2023Despite its efficacy, PrEP remains underutilized compared to the need for it. High costs are among the barriers to PrEP use, along with limited knowledge among clinicians, lack of health insurance, stigma, and underestimation of personal HIV risk.
Read More
Managing Editor of Managed Healthcare Executive, Peter Wehrwein, had a discussion with William Shrank, M.D., a venture partner with Andreessen Horowitz, a venture capital firm in Menlo Park, California, about how artificial intelligence's role is improving healthcare, where we are today with value-based care and the ongoing efforts of reducing waste in the healthcare space for this episode of the "What's on Your Mind" podcast series.
Listen
